United Health Products (OTCMKTS:UEEC) versus Envoy Medical (NASDAQ:COCH) Financial Contrast

United Health Products (OTCMKTS:UEEC) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Valuation & Earnings

This table compares United Health Products and Envoy Medical’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
United Health Products	$40,000.00	1,101.52	-$2.62 million	N/A	N/A
Envoy Medical	$320,000.00	143.33	-$29.91 million	N/A	N/A

United Health Products has higher earnings, but lower revenue than Envoy Medical.

Risk & Volatility

United Health Products has a beta of -0.37, suggesting that its stock price is 137% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.29, suggesting that its stock price is 129% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for United Health Products and Envoy Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
United Health Products	0	0	0	0	N/A
Envoy Medical	0	0	3	0	3.00

Envoy Medical has a consensus price target of $7.25, indicating a potential upside of 209.83%. Given Envoy Medical’s higher probable upside, analysts plainly believe Envoy Medical is more favorable than United Health Products.

Institutional & Insider Ownership

0.1% of United Health Products shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 1.5% of United Health Products shares are held by company insiders. Comparatively, 0.7% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares United Health Products and Envoy Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
United Health Products	N/A	N/A	-600.31%
Envoy Medical	N/A	N/A	-112.11%

Summary

Envoy Medical beats United Health Products on 6 of the 9 factors compared between the two stocks.

About United Health Products

United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.